Stay Mulled In Del. Suit Targeting Walmart Opioid Damages

By Jeff Montgomery (September 26, 2022, 8:38 PM EDT) -- Attorneys for Walmart stockholders were pressed by a Delaware vice chancellor Monday to explain why their massive opioid prescription oversight failure suit against the company shouldn't be stayed while pending U.S. Department of Justice action moves forward....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!